Literature DB >> 17895256

Socio-economic status, ethnicity and diabetes management: an analysis of time trends using the health survey for England.

Christopher Millett1, Sonia Saxena, Anthea Ng, Arch Mainous, Azeem Majeed.   

Abstract

BACKGROUND: The National Health Service (NHS) has invested substantially in recent years to reduce variations in health care for chronic conditions such as diabetes. We examined trends in the management of diabetes in England between socio-economic and ethnic groups from 1998 to 2004.
METHODS: Secondary analyses of Health Survey for England data comparing achievement of national treatment target for blood glucose, blood pressure and cholesterol and use of medications in survey respondents with diabetes.
RESULTS: The proportion of respondents with diabetes achieving national treatment targets increased significantly between 1998 and 2004. There was a significantly lower increase in blood pressure control in the black group [13.9% (95% confidence interval (CI) 13.0-14.8%)] but higher increase in south Asian and white Irish groups when compared to the white British group [15.7% (95% CI 15.4-16.0%)]. Manual workers experienced lower improvements in blood pressure control [15.3% (95% CI 14.9-15.7%) versus 16.7% (95% CI 16.2-17.2%)] but higher improvements in cholesterol control [10.3% (95% CI 9.7-10.9%) versus 7.4% (95% CI 6.8-8.0%)] when compared to non-manual workers.
CONCLUSION: There were considerable improvements in the management of diabetes in England during a period of sustained investment in health care quality but these were not distributed uniformly across ethnic and socio-economic groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895256     DOI: 10.1093/pubmed/fdm058

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  7 in total

1.  Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003-2012.

Authors:  N L Zaharan; D Williams; K Bennett
Journal:  Ir J Med Sci       Date:  2013-09-07       Impact factor: 1.568

2.  Ethnic and social disparity in glycaemic control in type 2 diabetes; cohort study in general practice 2004-9.

Authors:  Gareth D James; Peter Baker; Ellena Badrick; Rohini Mathur; Sally Hull; John Robson
Journal:  J R Soc Med       Date:  2012-03-06       Impact factor: 5.344

3.  A cluster randomized controlled trial of the effectiveness and cost-effectiveness of intermediate care clinics for diabetes (ICCD): study protocol for a randomized controlled trial.

Authors:  Natalie Armstrong; Darrin Baines; Richard Baker; Richard Crossman; Melanie Davies; Ainsley Hardy; Kamlesh Khunti; Sudhesh Kumar; Joseph Paul O'Hare; Neil Raymond; Ponnusamy Saravanan; Nigel Stallard; Ala Szczepura; Andrew Wilson
Journal:  Trials       Date:  2012-09-12       Impact factor: 2.279

4.  Biomarkers of diabetes risk in the National Diet and Nutrition Survey rolling programme (2008-2011).

Authors:  S Almoosawi; D Cole; S Nicholson; I Bayes; B Teucher; B Bates; J Mindell; S Tipping; C Deverill; A M Stephen
Journal:  J Epidemiol Community Health       Date:  2013-09-19       Impact factor: 3.710

5.  Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.

Authors:  Sophie V Eastwood; Rohini Mathur; Naveed Sattar; Liam Smeeth; Krishnan Bhaskaran; Nishi Chaturvedi
Journal:  PLoS Med       Date:  2021-06-29       Impact factor: 11.613

6.  A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010.

Authors:  Gerald Liew; Michel Michaelides; Catey Bunce
Journal:  BMJ Open       Date:  2014-02-12       Impact factor: 2.692

7.  Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial.

Authors:  Andrew Wilson; Joseph Paul O'Hare; Ainsley Hardy; Neil Raymond; Ala Szczepura; Ric Crossman; Darrin Baines; Kamlesh Khunti; Sudhesh Kumar; Ponnusamy Saravanan
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.